N.Y. budget proposal could roll back biomarker testing coverage, advocates say
Three years ago, New York state took a huge step forward expanding access to biomarker testing, which is said to be a game changer in cancer care. Now, however, advocates fear the state could be taking a step back for those with Medicaid. CBS News New York's Jenna DeAngelis reports.